Quetiapine Induced Neuroplasticity in Schizophrenic Patients: A Combined TMS [transcranial magnetic stimulation] and VBM [voxel-based morphometry] Study.

Trial Profile

Quetiapine Induced Neuroplasticity in Schizophrenic Patients: A Combined TMS [transcranial magnetic stimulation] and VBM [voxel-based morphometry] Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 May 2013

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 May 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2007-000545-35).
    • 21 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top